
TAU researchers suggest new target for Parkinson’s disease treatments
Researchers at Tel Aviv University (TAU) have found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of Parkinson’s pathology through nerve cells in the brain. The researchers say that their discovery of a new factor in the pathology of Parkinson’s disease may serve as a target for developing… Read More